Vimarsana
Biggest News Aggregation in the World

Page 15 - Forward Looking Statement News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Forward Looking Statement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Forward Looking Statement Today - Breaking & Trending Today

Bristol-Myers Squibb Company (NYSE:BMY) Q4 2023 Earnings Call Transcript - Vimarsana News

Bristol-Myers Squibb Company (NYSE:BMY) Q4 2023 Earnings Call Transcript

Bristol-Myers Squibb Company (NYSE:BMY) Q4 2023 Earnings Call Transcript February 2, 2024 Bristol-Myers Squibb Company isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Bristol-Myers Squibb Fourth Quarter 2023 Earnings Conference Call. All participants will be in listen-only […]

Source: yahoo.com
Bristol Myers Squibb (BMY) Q4 2023 Earnings Call Transcript - Vimarsana News

Bristol Myers Squibb (BMY) Q4 2023 Earnings Call Transcript

BMY earnings call for the period ending December 31, 2023.

Source: yahoo.com
West Bancorporation, Inc. (NASDAQ:WTBA) Q4 2023 Earnings Call Transcript - Vimarsana News

West Bancorporation, Inc. (NASDAQ:WTBA) Q4 2023 Earnings Call Transcript

West Bancorporation, Inc. (NASDAQ:WTBA) Q4 2023 Earnings Call Transcript January 25, 2024 West Bancorporation, Inc. misses on earnings expectations. Reported EPS is $0.29 EPS, expectations were $0.31. WTBA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, and welcome […]

Source: yahoo.com
Apellis Announces Negative CHMP Opinion for Pegcetacoplan for GA in the European Union and ... - Vimarsana News

Apellis Announces Negative CHMP Opinion for Pegcetacoplan for GA in the European Union and ...

WALTHAM, Mass., Jan. 26, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency

Cronos' Spinach® Brand Ends 2023 as the Number One Flower Brand in Canada1 -January 25, 2024 at 07:01 am EST - Vimarsana News

Cronos' Spinach® Brand Ends 2023 as the Number One Flower Brand in Canada1 -January 25, 2024 at 07:01 am EST

TORONTO, Jan. 25, 2024 -- Cronos Group Inc. , an innovative global cannabinoid company, today announced that its brand, Spinach®, closed 2023 as the number one ranked flower brand in Canada...